The growth potential of the weight-loss market could explode with advances, notably GLP-1 pills, and broader insurance coverage. That should change both health outcomes and the way Americas buy and ...

Sanctuary Wealth’s chief investment strategist says 2026 will be a “reset year” because of high valuations and challenging ...

The $2.3 trillion-asset independent broker-dealer’s chief wealth officer wants to make it easier for LPL’s 32,000 advisors to ...

Pot stocks fell for the second day Friday, but traders may be underestimating cost savings from Trump’s move to reclassify ...

Readers weigh in on Kevin Hassett, the Fed’s purchase of T-bills, a vote against Comcast and MSGS, and the case for Cal-Maine Foods ...

The Trump administration has talked tough about cutting drug prices, but the impacts of the deals with drug companies ...

Younger advisors are choosing gifts that connect with clients’ values and are sometimes opting for experiences over things.

Lamb Weston reported 44 cents in earnings per share, compared with the 25-cents loss a year earlier thanks to restructuring ...

Shares of AI infrastructure company CoreWeave soared 16% on Friday. Citi renewed coverage of CoreWeave shares with a Buy ...

Cannabis stocks remain under pressure after President Donald Trump signed an executive order Thursday directing the Department of Justice to reschedule marijuana as a lower-class drug.

It will take serious convincing for investors to return to Venezuela, Ben Cahill writes in a guest commentary.

Many individuals and companies are known to have had a relationship with Jeffrey Epstein. Will the expected Friday release of ...